• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Improvement of a rapid diagnostic application of monoclonal antibodies against avian influenza H7 subtype virus using Europium nanoparticles

tetano

Editor, Senior Moderator
Sci Rep. 2017 Aug 11;7(1):7933. doi: 10.1038/s41598-017-08328-9.
[h=1]Improvement of a rapid diagnostic application of monoclonal antibodies against avian influenza H7 subtype virus using Europium nanoparticles.[/h] Yeo SJ[SUP]1[/SUP], Bao DT[SUP]1[/SUP], Seo GE[SUP]2[/SUP], Bui CT[SUP]1[/SUP], Kim DTH[SUP]1[/SUP], Anh NTV[SUP]1[/SUP], Tien TTT[SUP]1[/SUP], Linh NTP[SUP]1[/SUP], Sohn HJ[SUP]2[/SUP], Chong CK[SUP]3[/SUP], Shin HJ[SUP]4[/SUP], Park H[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The development of a sensitive and rapid diagnostic test is needed for early detection of avian influenza (AI) H7 subtype. In this study, novel monoclonal antibodies (mAbs) against influenza A H7N9 recombinant hemagglutinin (rHA)1 were developed and applied to a Europium nanoparticle-based rapid fluorescent immunochromatographic strip test (FICT) to improve the sensitivity of the rapid diagnostic system. Two antibodies (2F4 and 6D7) exhibited H7 subtype specificity in a dot-FICT assay by optimization of the conjugate and the pH of the lysis buffer. The subtype specificity was confirmed by an immunofluorescence assay and Western blot analysis. The limit of detection of the FICT employing novel mAbs 31 ng/mL for H7N9 rHA1 and 40 hemagglutination units/mL for H7 subtype virus. Sensitivity was improved 25-fold using Europium as confirmed by comparison of colloidal gold-based rapid diagnostic kit using the 2F4 and 6D7 mAbs.


PMID: 28801679 DOI: 10.1038/s41598-017-08328-9
Free full text
 
Back
Top Bottom